Peripheral neuropathy in severe COVID‐19 resolved with therapeutic plasma exchange

Fahad Faqihi; Abdulrahman Alharthy; Ziad A. Memish; Demetrios J. Kutsogiannis; Peter G. Brindley; Dimitrios Karakitsos

doi:10.1002/ccr3.3397

Clinical Case Reports (Dec 2020)

Peripheral neuropathy in severe COVID‐19 resolved with therapeutic plasma exchange

Fahad Faqihi,
Abdulrahman Alharthy,
Ziad A. Memish,
Demetrios J. Kutsogiannis,
Peter G. Brindley,
Dimitrios Karakitsos

Affiliations

Fahad Faqihi: Critical Care Department King Saud Medical City Riyadh Saudi Arabia
Abdulrahman Alharthy: Critical Care Department King Saud Medical City Riyadh Saudi Arabia
Ziad A. Memish: Research and Innovation Center King Saud Medical City Riyadh Saudi Arabia
Demetrios J. Kutsogiannis: Department of Critical Care Faculty of Medicine and Dentistry The University of Alberta Edmonton AL Canada
Peter G. Brindley: Department of Critical Care Faculty of Medicine and Dentistry The University of Alberta Edmonton AL Canada
Dimitrios Karakitsos: Critical Care Department King Saud Medical City Riyadh Saudi Arabia

DOI: https://doi.org/10.1002/ccr3.3397
Journal volume & issue: Vol. 8, no. 12
pp. 3233 – 3238

Abstract

Read online

Abstract Peripheral neuropathies including Guillain‐Barré syndrome may be linked to life‐threatening COVID‐19. Plasma exchange is a safe rescue therapy in severe COVID‐19 with associated neurological manifestations and thromboinflammation.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/20500904

About the journal

Abstract

Keywords